{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:56:52Z","timestamp":1761490612210,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11136-018-1982-5","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T05:13:46Z","timestamp":1536124426000},"page":"3229-3241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2788-657X","authenticated-orcid":false,"given":"Loretta A.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9791-1227","authenticated-orcid":false,"given":"Meagan S.","family":"Whisenant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-5233","authenticated-orcid":false,"given":"Tito R.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shireen","family":"Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen N.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Cuffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1460-6527","authenticated-orcid":false,"given":"Charles S.","family":"Cleeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"issue":"7","key":"1982_CR1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.6004\/jnccn.2016.0087","volume":"14","author":"DS Ettinger","year":"2016","unstructured":"Ettinger, D. S., Wood, D. E., Akerley, W., Bazhenova, L. A., Borghaei, H., Camidge, D. R., et al. (2016). NCCN guidelines insights: Malignant pleural mesothelioma, Version 3.2016. Journal of the National Comprehensive Cancer Network, 14(7), 825\u2013836.","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"3","key":"1982_CR2","doi-asserted-by":"publisher","first-page":"00085","DOI":"10.15406\/jlprr.2016.03.00085","volume":"3","author":"A Cheepsattayakorn","year":"2016","unstructured":"Cheepsattayakorn, A., & Cheepsattayakorn, R. (2016). Malignant pleural mesothelioma: Occupational and non-occupational asbestos exposures. Journal of Lung, Pulmonary & Respiratory Research, 3(3), 00085.","journal-title":"Journal of Lung, Pulmonary & Respiratory Research"},{"issue":"8949","key":"1982_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(95)90462-X","volume":"345","author":"J Peto","year":"1995","unstructured":"Peto, J., Hodgson, J. T., Matthews, F. E., & Jones, J. R. (1995). Continuing increase in mesothelioma mortality in Britain. Lancet, 345(8949), 535\u2013539.","journal-title":"Lancet"},{"issue":"3","key":"1982_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/cncr.20315","volume":"101","author":"PJ Hollen","year":"2004","unstructured":"Hollen, P. J., Gralla, R. J., Liepa, A. M., Symanowski, J. T., & Rusthoven, J. J. (2004). Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: Using the LCSS-meso conceptual model for validation. Cancer, 101(3), 587\u2013595.","journal-title":"Cancer"},{"issue":"3","key":"1982_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/jso.21261","volume":"100","author":"V Ambrogi","year":"2009","unstructured":"Ambrogi, V., Mineo, D., Gatti, A., Pompeo, E., & Mineo, T. C. (2009). Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma. Journal of Surgical Oncology, 100(3), 199\u2013204.","journal-title":"Journal of Surgical Oncology"},{"issue":"26","key":"1982_CR6","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMp1011024","volume":"363","author":"ME Porter","year":"2010","unstructured":"Porter, M. E. (2010). What is value in health care? New England Journal of Medicine, 363(26), 2477\u20132481.","journal-title":"New England Journal of Medicine"},{"key":"1982_CR7","unstructured":"US Department of Health and Human Services Food and Drug Administration (2009). Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. Retrieved March 19, 2018 from http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf ."},{"issue":"8","key":"1982_CR8","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s11136-010-9677-6","volume":"19","author":"KE Lasch","year":"2010","unstructured":"Lasch, K. E., Marquis, P., Vigneux, M., Abetz, L., Arnould, B., Bayliss, M., et al. (2010). PRO development: Rigorous qualitative research as the crucial foundation. Quality of Life Research, 19(8), 1087\u20131096.","journal-title":"Quality of Life Research"},{"issue":"8","key":"1982_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K., Martin, M. L., Molsen, E., et al. (2011). Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1\u2014eliciting concepts for a new PRO instrument. Value in Health, 14(8), 967\u2013977.","journal-title":"Value in Health"},{"issue":"8","key":"1982_CR10","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1524-4733.2009.00603.x","volume":"12","author":"M Rothman","year":"2009","unstructured":"Rothman, M., Burke, L., Erickson, P., Leidy, N. K., Patrick, D. L., & Petrie, C. D. (2009). Use of existing patient-reported outcome (PRO) instruments and their modification: The ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force report. Value in Health, 12(8), 1075\u20131083.","journal-title":"Value in Health"},{"issue":"7","key":"1982_CR11","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V","volume":"89","author":"CS Cleeland","year":"2000","unstructured":"Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., et al. (2000). Assessing symptom distress in cancer patients: The M.D. Anderson Symptom Inventory. Cancer, 89(7), 1634\u20131646.","journal-title":"Cancer"},{"key":"1982_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/jncimonographs\/lgm005","volume":"37","author":"CS Cleeland","year":"2007","unstructured":"Cleeland, C. S. (2007). Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. Journal of the National Cancer Institute. Monographs, 37, 16\u201321.","journal-title":"Journal of the National Cancer Institute. Monographs"},{"issue":"1","key":"1982_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clgc.2013.07.003","volume":"12","author":"D Jones","year":"2014","unstructured":"Jones, D., Zhao, F., Fisch, M. J., Wagner, L. I., Patrick-Miller, L. J., Cleeland, C. S., et al. (2014). The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: Evidence from the symptom outcomes and practice patterns (SOAPP) data from the Eastern Cooperative Oncology Group. Clinical Genitourinary Cancer, 12(1), 41\u201349.","journal-title":"Clinical Genitourinary Cancer"},{"issue":"5","key":"1982_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.clbc.2013.02.014","volume":"13","author":"TR Mendoza","year":"2013","unstructured":"Mendoza, T. R., Zhao, F., Cleeland, C. S., Wagner, L. I., Patrick-Miller, L. J., & Fisch, M. J. (2013). The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: Evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group. Clinical Breast Cancer, 13(5), 325\u2013334.","journal-title":"Clinical Breast Cancer"},{"issue":"4","key":"1982_CR15","first-page":"421","volume":"12","author":"TS Armstrong","year":"2010","unstructured":"Armstrong, T. S., Gning, I., Mendoza, T. R., Vera-Bolanos, E., Gilbert, M. R., Rhines, L. D., et al. (2010). Reliability and validity of the M. D. Anderson Symptom Inventory-spine tumor module. Journal of Neurosurgery: Spine, 12(4), 421\u2013430.","journal-title":"Journal of Neurosurgery: Spine"},{"issue":"1","key":"1982_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11060-006-9135-z","volume":"80","author":"TS Armstrong","year":"2006","unstructured":"Armstrong, T. S., Mendoza, T., Gning, I., Coco, C., Cohen, M. Z., Eriksen, L., et al. (2006). Validation of the M.D. Anderson Symptom Inventory brain tumor module (MDASI-BT). Journal of Neuro-Oncology, 80(1), 27\u201335.","journal-title":"Journal of Neuro-Oncology"},{"issue":"6","key":"1982_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cardfail.2008.01.012","volume":"14","author":"A Fadol","year":"2008","unstructured":"Fadol, A., Mendoza, T., Gning, I., Kernicki, J., Symes, L., Cleeland, C. S., et al. (2008). Psychometric testing of the MDASI-HF: A symptom assessment instrument for patients with cancer and concurrent heart failure. Journal of Cardiac Failure, 14(6), 497\u2013507.","journal-title":"Journal of Cardiac Failure"},{"issue":"1","key":"1982_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000178809","volume":"76","author":"I Gning","year":"2009","unstructured":"Gning, I., Trask, P. C., Mendoza, T. R., Harle, M. T., Gutierrez, K. A., Kitaka, S. A., et al. (2009). Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory. Oncology, 76(1), 59\u201368.","journal-title":"Oncology"},{"issue":"2","key":"1982_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1634\/theoncologist.2010-0193","volume":"16","author":"TR Mendoza","year":"2011","unstructured":"Mendoza, T. R., Wang, X. S., Lu, C., Palos, G. R., Liao, Z., Mobley, G. M., et al. (2011). Measuring the symptom burden of lung cancer: The validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. The Oncologist, 16(2), 217\u2013227.","journal-title":"The Oncologist"},{"issue":"10","key":"1982_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/hed.20602","volume":"29","author":"DI Rosenthal","year":"2007","unstructured":"Rosenthal, D. I., Mendoza, T. R., Chambers, M. S., Asper, J. A., Gning, I., Kies, M. S., et al. (2007). Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module. Head and Neck, 29(10), 923\u2013931.","journal-title":"Head and Neck"},{"issue":"2","key":"1982_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ygyno.2013.05.009","volume":"130","author":"MH Sailors","year":"2013","unstructured":"Sailors, M. H., Bodurka, D. C., Gning, I., Ramondetta, L. M., Williams, L. A., Mendoza, T. R., et al. (2013). Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecologic Oncology, 130(2), 323\u2013328.","journal-title":"Gynecologic Oncology"},{"issue":"8","key":"1982_CR22","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/cncr.24920","volume":"116","author":"XS Wang","year":"2010","unstructured":"Wang, X. S., Williams, L. A., Eng, C., Mendoza, T. R., Shah, N. A., Kirkendoll, K. J., et al. (2010). Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer, 116(8), 2053\u20132063.","journal-title":"Cancer"},{"issue":"6","key":"1982_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jpainsymman.2013.02.007","volume":"46","author":"LA Williams","year":"2013","unstructured":"Williams, L. A., Agarwal, S., Bodurka, D. C., Saleeba, A. K., Sun, C. C., & Cleeland, C. S. (2013). Capturing the patient\u2019s experience: Using qualitative methods to develop a measure of patient-reported symptom burden: An example from ovarian cancer. Journal of Pain and Symptom Management, 46(6), 837\u2013845.","journal-title":"Journal of Pain and Symptom Management"},{"issue":"24","key":"1982_CR24","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1002\/cncr.28376","volume":"119","author":"CS Cleeland","year":"2013","unstructured":"Cleeland, C. S., Zhao, F., Chang, V. T., Sloan, J. A., O\u2019Mara, A. M., Gilman, P. B., et al. (2013). The symptom burden of cancer: evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer, 119(24), 4333\u20134340.","journal-title":"Cancer"},{"issue":"7","key":"1982_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/dju129","volume":"106","author":"BB Reeve","year":"2014","unstructured":"Reeve, B. B., Mitchell, S. A., Dueck, A. C., Basch, E., Cella, D., Reilly, C. M., et al. (2014). Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. Journal of the National Cancer Institute, 106(7), 1\u20138.","journal-title":"Journal of the National Cancer Institute"},{"issue":"7","key":"1982_CR26","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00520-015-2732-7","volume":"23","author":"A Aktas","year":"2015","unstructured":"Aktas, A., Walsh, D., & Kirkova, J. (2015). The psychometric properties of cancer multisymptom assessment instruments: A clinical review. Supportive Care in Cancer, 23(7), 2189\u20132202.","journal-title":"Supportive Care in Cancer"},{"issue":"10","key":"1982_CR27","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/jnci\/djq097","volume":"102","author":"XS Wang","year":"2010","unstructured":"Wang, X. S., Cleeland, C. S., Mendoza, T. R., Yun, Y. H., Wang, Y., Okuyama, T., et al. (2010). Impact of cultural and linguistic factors on symptom reporting by patients with cancer. Journal of the National Cancer Institute, 102(10), 732\u2013738.","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"1982_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41687-018-0039-4","volume":"2","author":"HL Gelhorn","year":"2017","unstructured":"Gelhorn, H. L., Eremenco, S., Skalicky, A. M., Balantac, Z., Cimms, T., Halling, K., et al. (2017). Content validity and ePRO usability of the BPI-sf and \u201cworst pain\u201d item with pleural and peritoneal mesothelioma. Journal of Patient-Reported Outcomes, 2(1), 16.","journal-title":"Journal of Patient-Reported Outcomes"},{"key":"1982_CR29","unstructured":"PRISMA (2015). PRISMA: Transparent reporting of systemic reviews and meta-analyses. Retrievd April 17, 2018 http:\/\/www.prisma-statement.org"},{"issue":"Suppl 2","key":"1982_CR30","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1111\/j.1524-4733.2007.00271.x","volume":"10","author":"RR Turner","year":"2007","unstructured":"Turner, R. R., Quittner, A. L., Parasuraman, B. M., Kallich, J. D., & Cleeland, C. S. (2007). Patient-reported outcomes: Instrument development and selection issues. Value in Health, 10(Suppl 2), S86\u2013S93.","journal-title":"Value in Health"},{"key":"1982_CR31","volume-title":"Nursing research: Qualitative methods","author":"RR Parse","year":"1985","unstructured":"Parse, R. R., Coyne, A. B., & Smith, M. J. (1985). Nursing research: Qualitative methods. Bowie: Brady Communications."},{"issue":"Suppl 1","key":"1982_CR32","first-page":"S133","volume":"24","author":"LA Williams","year":"2016","unstructured":"Williams, L. A., Mendoza, T. R., Shi, Q., Wang, X. S., Haq, S., Ali, N. N., et al. (2016). Measuring treatment-induced peripheral neuropathy in patients with cancer: The treatment-induced Peripheral Neuropathy Scale (TNAS) [abstract]. Multinational Association of Supportive Care in Cancer\/International Society of Oral Oncology (MASCC\/ISOO) 2016 Annual Meeting, Adelaide, Australia, Jun 23\u201325, 2016. Supportive Care in Cancer 24(Suppl 1), S133. Abstract #eP152.","journal-title":"Supportive Care in Cancer"},{"issue":"23","key":"1982_CR33","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/blood.V126.23.2094.2094","volume":"126","author":"LA Williams","year":"2015","unstructured":"Williams, L. A., Garcia-Gonzalez, A., Aheneku, H. O., Cortes, J. E., Garcia-Manero, G., Kantarjian, H. M., et al. (2015) A patient-reported outcome measure for symptoms and symptom burden of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) [abstract]. American Society of Hematology (ASH) 57th Annual Meeting, Orlando FL, Dec 5\u20139, 2015. Blood 126(23), 2094\u20132095. Abstract #2094.","journal-title":"Blood"},{"issue":"5","key":"1982_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1182\/blood-2013-01-477687","volume":"122","author":"LA Williams","year":"2013","unstructured":"Williams, L. A., Garcia Gonzalez, A. G., Ault, P., Mendoza, T. R., Sailors, M. L., Williams, J. L., et al. (2013). Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood, 122(5), 641\u2013647.","journal-title":"Blood"},{"issue":"2 Suppl 2","key":"1982_CR35","first-page":"24","volume":"16","author":"LA Williams","year":"2010","unstructured":"Williams, L. A., Couriel, D. R., Mendoza, T. R., McCarthy, P. L., Neumann, J. L., White, M. H., et al. (2010). A new measure of symptom burden in chronic graft-versus-host disease [abstract]. American Society for Blood and Marrow Transplantation 2010 BMT Tandem Meetings, Orlando FL. Biology of Blood and Marrow Transplantation, 16(2 Suppl 2), 24\u201328. S177. Abstract #60.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"15 Suppl","key":"1982_CR36","doi-asserted-by":"crossref","first-page":"e17508","DOI":"10.1200\/jco.2013.31.15_suppl.e17508","volume":"31","author":"LA Williams","year":"2013","unstructured":"Williams, L. A., Araujo, D. M., Mendoza, T. R., Sailors, M. L., Ali, N. N., Huang, F., et al. (2013). A new symptom measure in gastrointestinal stromal tumors [abstract]. American Society of Clinical Oncology 49th Annual Meeting, Chicago IL, May 31\u2013Jun 4, 2013. Journal of Clinical Oncology, 31(15 Suppl), e17508. Abstract #e17508.","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"1982_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365\u2013376.","journal-title":"Journal of the National Cancer Institute"},{"issue":"15","key":"1982_CR38","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1200\/JCO.2004.09.147","volume":"22","author":"AK Nowak","year":"2004","unstructured":"Nowak, A. K., Stockler, M. R., & Byrne, M. J. (2004). Assessing quality of life during chemotherapy for pleural mesothelioma: Feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. Journal of Clinical Oncology, 22(15), 3172\u20133180.","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"1982_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0959-8049(94)90535-5","volume":"30A","author":"B Bergman","year":"1994","unstructured":"Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: A modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. European Journal of Cancer, 30A(5), 635\u2013642.","journal-title":"European Journal of Cancer"},{"key":"1982_CR40","unstructured":"Johnson, C., Aaronson, N., Blazeby, J. M., Bottomley, A., Fayers, P., Koller, M., et al. (2011). Guidelines for developing questionnaire modules. (4th edition). Retrieved July 11, 2018 from http:\/\/groups.eortc.be\/qol\/sites\/default\/files\/archives\/guidelines_for_developing_questionnaire-_final.pdf"},{"issue":"6","key":"1982_CR41","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.hoc.2005.09.003","volume":"19","author":"H Clayson","year":"2005","unstructured":"Clayson, H., Seymour, J., & Noble, B. (2005). Mesothelioma from the patient\u2019s perspective. Hematology\/Oncology Clinics of North America, 19(6), 1175\u20131190.","journal-title":"Hematology\/Oncology Clinics of North America"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-018-1982-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-018-1982-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-018-1982-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T22:55:02Z","timestamp":1604876102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-018-1982-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1982"],"URL":"https:\/\/doi.org\/10.1007\/s11136-018-1982-5","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"type":"print","value":"0962-9343"},{"type":"electronic","value":"1573-2649"}],"subject":[],"published":{"date-parts":[[2018,9,5]]},"assertion":[{"value":"28 August 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The MD Anderson Symptom Inventory is copyrighted and licensed by The University of Texas MD Anderson Cancer Center and Charles S. Cleeland. Karen Keating and Brian Cuffel are employees of Bayer HealthCare, the sponsor of the study. The authors report no other conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board of The University of Texas MD Anderson Cancer Center and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}